Liquid Embolic Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Description

Persistence Market Research has recently released a comprehensive report on the global Liquid Embolic Market, offering an in-depth assessment of key market dynamics such as growth drivers, emerging trends, opportunities, challenges, and the competitive landscape. The report provides valuable insights to help industry participants, investors, and healthcare stakeholders make informed strategic decisions.

Key Insights:

Liquid Embolic Market Size (2025E): US$ 384.2 Mn
Projected Market Value (2032F): US$ 703.6 Mn
Global Market Growth Rate (CAGR 2025 to 2032): 9.0%

Liquid Embolic Market - Report Scope:

The liquid embolic market comprises minimally invasive embolization agents used primarily in neurovascular and oncological interventions to block abnormal blood vessels. Liquid embolics are widely utilized in the treatment of brain arteriovenous malformations, aneurysms, dural arteriovenous fistulas, and tumor embolization procedures. Their ability to precisely occlude targeted vessels with improved procedural control has made them a preferred choice among interventional radiologists and neurosurgeons. The rising prevalence of neurovascular disorders, increasing adoption of minimally invasive procedures, and continuous advancements in embolic material technology are driving the expansion of the global liquid embolic market.

Market Growth Drivers:

The growth of the global liquid embolic market is primarily driven by the increasing incidence of neurovascular diseases such as brain aneurysms, arteriovenous malformations, and dural arteriovenous fistulas. Advancements in imaging and catheter-based technologies have improved the safety and efficacy of embolization procedures, encouraging wider adoption of liquid embolic agents. Additionally, the growing preference for minimally invasive treatments over conventional surgical approaches has significantly increased demand for liquid embolics in hospitals and specialty centers. Rising healthcare expenditure, expanding access to advanced neurointerventional care, and increasing awareness among clinicians regarding the benefits of liquid embolic systems further contribute to market growth.

Market Restraints:

Despite strong growth prospects, the liquid embolic market faces certain challenges that may limit its expansion. The high cost of liquid embolic products and embolization procedures can restrict adoption, particularly in cost-sensitive and developing healthcare markets. Moreover, the complexity of embolization techniques requires highly skilled professionals, and a shortage of trained interventional specialists can hinder market penetration. Potential risks such as non-target embolization and procedure-related complications may also restrain wider acceptance, especially in less experienced clinical settings.

Market Opportunities:

The liquid embolic market presents significant opportunities fueled by ongoing innovation in embolic materials and delivery systems. The development of next-generation liquid embolics with improved visibility, controlled precipitation, and enhanced safety profiles is expected to expand clinical applications. Emerging markets in Asia-Pacific, Latin America, and the Middle East & Africa offer substantial growth potential due to improving healthcare infrastructure and rising investments in advanced interventional procedures. Additionally, increasing applications of liquid embolics in oncology and peripheral vascular interventions, along with strategic collaborations between manufacturers and healthcare institutions, are expected to unlock new avenues for market expansion.

Key Questions Answered in the Report:

What are the major factors driving the growth of the global liquid embolic market?
Which indications and end-user segments are contributing most to market demand?
How are technological advancements shaping the future of liquid embolic products?
Who are the key players in the liquid embolic market, and what competitive strategies are they adopting?
What are the regional trends and future growth prospects of the liquid embolic market?

Competitive Analysis:

The global liquid embolic market is moderately competitive, with key players focusing on product innovation, portfolio expansion, and strategic partnerships to strengthen their market presence. Companies are investing in advanced embolic materials and expanding their geographical footprint to gain a competitive edge.

Competitive Analysis:

Cerenovus (Johnson & Johnson)
Medtronic
Sirtex Medical Inc.
Terumo Neuro
Balt
Meril Life Sciences Pvt. Ltd.
INVAMED
Peters Surgical

Market Segmentation

By Product:

Liquid Embolic Vials
Prefilled Injectables

By Indication:

Brain Arterio-Venous Malformations (bAVM)
Tumor Embolization
Brain Aneurysm
Dural Arteriovenous Fistulas (dAVFs)
Others

By End-user:

Hospitals
Ambulatory Surgical Centers
Independent Specialty Centres
Others

By Region:

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East & Africa

Product Code: PMRREP25513

1. Executive Summary

1.1. Global Liquid Embolic Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Product Adoption Analysis
3.2. Disease Epidemiology - Neurology Disorders
3.3. Regulatory Landscape
3.4. PESTLE Analysis
3.5. Porter's Five Force Analysis
3.6. Promotional Strategies, By Key Players

4. Global Liquid Embolic Market Outlook

4.1. Key Highlights
- 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
4.3. Global Liquid Embolic Market Outlook: Product
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2024
- 4.3.3. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  - 4.3.3.1. Liquid Embolic Vials
  - 4.3.3.2. Prefilled Injectables
- 4.3.4. Market Attractiveness Analysis: Product
4.4. Global Liquid Embolic Market Outlook: Indication
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Mn), By Indication, 2019-2024
- 4.4.3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
  - 4.4.3.1. Brain Arterio-Venous Malformations (bAVM)
  - 4.4.3.2. Tumor Embolization
  - 4.4.3.3. Brain Aneurysm
  - 4.4.3.4. Dural Arteriovenous Fistulas (dAVFs)
  - 4.4.3.5. Others
- 4.4.4. Market Attractiveness Analysis: Indication
4.5. Global Liquid Embolic Market Outlook: End User
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Mn), By End User, 2019-2024
- 4.5.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  - 4.5.3.1. Hospitals
  - 4.5.3.2. Ambulatory Surgical Centers (ASCs)
  - 4.5.3.3. Independent Specialty Centers
  - 4.5.3.4. Others
- 4.5.4. Market Attractiveness Analysis: End User

5. Global Liquid Embolic Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
5.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Liquid Embolic Market Outlook

6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 6.2.1. By Country
- 6.2.2. By Product
- 6.2.3. By Indication
- 6.2.4. By End User
6.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 6.4.1. Liquid Embolic Vials
- 6.4.2. Prefilled Injectables
6.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 6.5.1. Brain Arterio-Venous Malformations (bAVM)
- 6.5.2. Tumor Embolization
- 6.5.3. Brain Aneurysm
- 6.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 6.5.5. Others
6.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 6.6.1. Hospitals
- 6.6.2. Ambulatory Surgical Centers (ASCs)
- 6.6.3. Independent Specialty Centers
- 6.6.4. Others
6.7. Market Attractiveness Analysis

7. Europe Liquid Embolic Market Outlook

7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Indication
- 7.2.4. By End User
7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
7.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 7.4.1. Liquid Embolic Vials
- 7.4.2. Prefilled Injectables
7.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 7.5.1. Brain Arterio-Venous Malformations (bAVM)
- 7.5.2. Tumor Embolization
- 7.5.3. Brain Aneurysm
- 7.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 7.5.5. Others
7.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 7.6.1. Hospitals
- 7.6.2. Ambulatory Surgical Centers (ASCs)
- 7.6.3. Independent Specialty Centers
- 7.6.4. Others
7.7. Market Attractiveness Analysis

8. East Asia Liquid Embolic Market Outlook

8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Indication
- 8.2.4. By End User
8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 8.4.1. Liquid Embolic Vials
- 8.4.2. Prefilled Injectables
8.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 8.5.1. Brain Arterio-Venous Malformations (bAVM)
- 8.5.2. Tumor Embolization
- 8.5.3. Brain Aneurysm
- 8.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 8.5.5. Others
8.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 8.6.1. Hospitals
- 8.6.2. Ambulatory Surgical Centers (ASCs)
- 8.6.3. Independent Specialty Centers
- 8.6.4. Others
8.7. Market Attractiveness Analysis

9. South Asia & Oceania Liquid Embolic Market Outlook

9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Indication
- 9.2.4. By End User
9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 9.4.1. Liquid Embolic Vials
- 9.4.2. Prefilled Injectables
9.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 9.5.1. Brain Arterio-Venous Malformations (bAVM)
- 9.5.2. Tumor Embolization
- 9.5.3. Brain Aneurysm
- 9.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 9.5.5. Others
9.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 9.6.1. Hospitals
- 9.6.2. Ambulatory Surgical Centers (ASCs)
- 9.6.3. Independent Specialty Centers
- 9.6.4. Others
9.7. Market Attractiveness Analysis

10. Latin America Liquid Embolic Market Outlook

10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Indication
- 10.2.4. By End User
10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 10.4.1. Liquid Embolic Vials
- 10.4.2. Prefilled Injectables
10.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 10.5.1. Brain Arterio-Venous Malformations (bAVM)
- 10.5.2. Tumor Embolization
- 10.5.3. Brain Aneurysm
- 10.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 10.5.5. Others
10.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 10.6.1. Hospitals
- 10.6.2. Ambulatory Surgical Centers (ASCs)
- 10.6.3. Independent Specialty Centers
- 10.6.4. Others
10.7. Market Attractiveness Analysis

11. Middle East & Africa Liquid Embolic Market Outlook

11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Indication
- 11.2.4. By End User
11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 11.4.1. Liquid Embolic Vials
- 11.4.2. Prefilled Injectables
11.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 11.5.1. Brain Arterio-Venous Malformations (bAVM)
- 11.5.2. Tumor Embolization
- 11.5.3. Brain Aneurysm
- 11.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 11.5.5. Others
11.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 11.6.1. Hospitals
- 11.6.2. Ambulatory Surgical Centers (ASCs)
- 11.6.3. Independent Specialty Centers
- 11.6.4. Others
11.7. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2024
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Cerenovus (J&J)
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Products
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. Medtronic
- 12.3.3. Sirtex Medical Inc.
- 12.3.4. Terumo Neuro
- 12.3.5. Balt
- 12.3.6. Meril Life Sciences Pvt. Ltd
- 12.3.7. INVAMED
- 12.3.8. Peters Surgical

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations